Abstract: The electrotransfer of a nucleic acid into tissue cells, in particular in a muscle or a tumoral tissue, is carried out by an electric stimulation of the tissue as follows: first with at least one, preferably a single, pulse of a High Voltage field strength of between 200 and 2000 volts/cm second with a single pulse of Low Voltage field strength of between 50 and 200 volts/cm and of duration of between 300 ms and 2000 ms.

Abstract: The present invention relates to a method for continuously preparing mineral particles by means of the thermolysis of mineral precursors in an aqueous medium, comprising contacting: a reactive flow, including mineral precursors at a temperature lower than the conversion temperature thereof; and a coolant flow that is countercurrent to said reactive flow and contains water at a temperature that is sufficient to bring the precursors to a temperature higher than the conversion temperature thereof, the mixture flow that results from said reactive flow and said coolant flow then being conveyed into a tubular reactor, inside of which particles are formed by gradually converting the precursors, and where the reactive flow and the coolant flow are placed in contact with each other inside a mixing chamber, inside of which the reactive flow and the coolant flow are fed by supply pipes having outlet cross-sections that are smaller than the maximum cross-section of said mixing chamber.

Abstract: A method and device includes measuring a multiple-phase fluid flowing through a pipe. The inventive method includes the following steps in which: a fluid is illuminated using a first coaxial probe placed in contact with the liquid phase of the fluid, and a first electromagnetic wave is emitted at a high frequency. The admittance at the interface between the first probe and the fluid is measured, and the fractions of at least two constituents of the liquid phase are calculated in order to obtain the effective permittivity (?1) of the phase. The method also includes the following steps in which: the fluid is illuminated using a second coaxial probe and a second electromagnetic wave is emitted at a low frequency. The admittance at the interface between the second probe and the liquid is measured, and the thickness (e) of the liquid is measured. The aforementioned calculation is performed on the basis of the calculated effective permittivity (?1) and the admittance measured by the second probe.

Abstract: The invention concerns a method for preparing a grafted material comprising the following steps: a) providing a material which, on its surface, comprises sp3 hybridized carbon, silicon and/or germanium atoms carrying at least one hydrogen atom, and b) contacting in a solvent the material such as provided at step a) with a compound (C) carrying at least one amine function in the unprotonated state, whereby the said compound (C) is grafted onto the said material.

Abstract: The present application relates to a method for preparing epoxy resins from a mixture of epoxidized phenolic compounds, wherein said epoxidized phenolic compounds are obtained by the epoxidation of natural phenolic compounds selected from the group comprising simple phenol, acid-phenol, coumarin, naphthoquinone, stillbenoid, flavonoid, isoflavanoid, anthocyanin, condensed tannin and hydrolyzable tannin.

Abstract: A method for preparing a composition of metal oxide nanocrystals from at least one organometallic precursor in an aprotic solvent in the presence of at least one PEG ligand including a carbon chain having at least one end functionalized by a coordinating group containing at least one heteroatom, and at least one [—OCH2CH2]n, group, such that it is soluble in both the aprotic solvent medium and in water. The resulting water-compatible and organocompatible composition of metal oxide nanocrystals is also described.

Abstract: The invention concerns a compound comprising a combination of two crystal phases. The first crystal phase corresponds to the formula: AaEbVcModPeOfHg wherein A is an alkali-metal; E is Te, Sb or Bi; and 0?a?3, 0<b?3, 0?c?3, 0<d?13, 0<e?2, 0?g?3. The second crystal phase corresponds to the formula ZgMohXiOj wherein: Z is selected among trivalent rare earths; X is selected among the elements V, Ga, Fe, Bi, Ce, Ti, Sb, Mn, Zn, Te; and 0<g?3, 0?h?3, 0?i?1. The indices f and j represent the number of oxygen atoms required for satisfying the relative valency and atomic proportions of the elements present. The invention also concerns the method for preparing said compound, and its use in particular as catalyst for oxidizing alkanes.

Abstract: The invention relates to a method for preparing a synthetic talc composition. According to said method, a kerolite composition is subjected to an anhydrous thermal treatment carried out at a pressure lower than 5 bar, from over a few hours up to over a few days, at a treatment temperature higher than 300° C. The invention also relates to a synthetic talc composition prepared in this way, the synthetic talc particles of the composition being exclusively of chemical formula —(Si4)Mg3O10(OH)2— and identifiable, during X-ray diffraction, by the presence of a characteristic diffraction peak located at a distance of between 9.40-9.68 and corresponding to a plane (001). Said synthetic talc particles also have a thermally stable crystalline structure of stacked laminae, which is very similar to that of a natural talc and has a particle size smaller than approximately ten micrometers.

Abstract: A method for producing hydrogen comprising the steps of: i) contacting a compound (C) comprising one or more groups Si—H with an amine based catalyst in a solvent selected from an alcohol or an aqueous solution, thereby forming hydrogen and a by-product (C1); wherein said amine based catalyst is as defined in claim 1; ii) recovering the obtained hydrogen.

Abstract: The present invention relates to the use of composite materials as thickening agents for aqueous solutions, said material comprising carbon nanotubes (CNTs) and at least one hydrophilic (co)polymers. The invention relates more particularly to the use of the materials described above as thickening agents n one of the fields chosen: from the following: the papermaking field, the oil field and also the fields of paint, water treatment, detergents, ceramics, cements, or hydraulic binders, civil engineering, inks and varnishes, and textile sizing.

Abstract: The endoprosthesis is designed to be implanted in an aneurysm (12) of a patient, the aneurysm (12) resulting from deformation of a vessel wall, in particular the wall of an artery (14), the endoprosthesis including: a tubular envelope (22, 24) that extends in a direction (Y-Y?), and a plurality of pressure probes (26) fixed on the envelope (22, 24), each probe (26) including: a sensor (28) for measuring pressure, and elements (34, 36) for transmitting the pressure measurement to a monitoring apparatus located outside the patient. The elements (34, 36) for transmitting the pressure measurement from each probe (26) are designed to generate an electromagnetic pressure measurement transmission signal including at least one distinctive characteristic of the probe (26) of which these elements (34, 36) form part.

Abstract: A filter with coupled resonator having a substrate; an acoustic mirror intended to support acoustic resonators, and to isolate these resonators from the substrate; a first structure with an upper resonator and a lower resonator coupled to one another through at least one layer of acoustic coupling; a second structure with an upper resonator and a lower resonator coupled to one another through at least one layer of acoustic coupling; the lower resonators of the first and second structure having the same electrodes. The first and second structures are connected via a fifth resonator for which electrodes and the piezoelectric layer of the lower resonators are of the first and second structure.

Abstract: The present invention relates to materials exhibiting the property of rubbery elasticity, consisting of molecules with a mass of between 9 and 9000 g/mol, all or some of the molecules having at least three groups (also referred to as “associative groups”) capable of associating via non-covalent interactions. Although consisting of small non-polymerized molecules that are not chemically crosslinked, this material exhibits properties of rubbery elasticity. According to an embodiment of the invention, this material exhibits rubbery elasticity at ambient temperature. Above a certain temperature, the material flows like a simple liquid. The material is thermoreversible, i.e. after cooling, the material again exhibits the property of rubbery elasticity. This material is self-repairing and potentially recyclable, which is never the case with a chemically crosslinked elastomer.

Abstract: The invention concerns dual molecules corresponding to formula (I): in which: A represents a molecular residue with antimalarial activity of formula (IIa) or (IIIa) or a residue facilitating bioavailability; B represents a cycloalkyl group potentially substituted, or B represents a bi- or tricyclic group capable of being substituted, or B represents 2 cycloalkyl groups linked together through either a single bond or an alkylene chain; m and n represent independently of one another 0, 1 or 2; R5 represents a hydrogen atom, an alkyl, cycloalkyl or C1-3-alkylene-cycloakyl group; Z1 and Z2 represent an alkyl radical, the group Z1+Z2+Ci+Cj representing a mono- or polycyclic structure, with one of the Z1 or Z2 being able to represent a single bond; R1 and R2, identical or different, represent a hydrogen atom or a functional group capable of increasing hydrosolubility; Rx and Ry forming together a cyclic peroxide including 4 to 8 links and including 1 or 2 additional oxygen atoms in the cyclic structure, possibly su

Abstract: The present invention relates to a galliated calcium-phosphate biomaterial comprising a gallium-doped phosphocalcic compound of formula (I): Ca(005-1 5X)Gax(PO—O4)7, wherein 0<x<1 and the salts, hydrates and mixtures thereof and/or a calcium deficient apatite structure with in particular a (Ca+Ga)/P molar ratio in the range of 1.3 to 1.67, and a gallium content up to 4.5% by weight. It also relates to processes of preparation of such materials and uses thereof, in particular as dental or bony implants. It further relates to a kit comprising a galliated calcium-phosphate biomaterial in combination with a fluid component. It finally relates to methods of use of the galliated calcium-phosphate biomaterial, notably for III) ions increase radio-opacity after bone implantation and can be released for inhibiting bone resorption.

Abstract: An antenna uses a photonic forbidden band (PFB) material in which, by default, a surface (26) for injecting and/or receiving electromagnetic waves in a resonance cavity of the antenna (8) has at least a width or a length of a diameter higher than or equal to the wavelength of the working frequency.

Abstract: The present invention relates to compounds having the following general formula (I): wherein: A represents a SO2 or CX group, X representing O or S; R1, R2, R?, R4 represent in particular H, R represents in particular an alkyl group or an aryl group, as well as to the pharmaceutically acceptable salts thereof, the compound of formula (I) taking the form of a pure stereoisomer or an enantiomer and/or diastereoisomer mixture, including racemic mixtures.

Abstract: This eddy current imaging method includes the steps of: positioning (72), in the vicinity of a large inspection region, elements for the measurement of a surface magnetic field, generating (74, 92) a global exciting magnetic field over the observation inspection region, measuring (76, 84) a resultant magnetic field at the surface, in the form of images, processing (90) the images. The generating step (74, 82) involves generating a set of at least two exciting magnetic field waveforms; the measuring step (76, 86) involves measuring a set of configurations of the resultant magnetic field in the form of images; the step (90) of treating the images by combining them allows defects to be detected and the position and the nature thereof to be determined.

Abstract: In one embodiment, the present invention relates to novel mu-conotoxin peptides, biologically active fragments thereof, combinations thereof and/or variants thereof. An embodiment of the invention also relates to their use in pharmaceutical composition for the treatment or prevention of pain, and their use in the preparation of an anesthetic.

Abstract: The present invention relates to compounds of the following general formula: (I) wherein R1 and R2 are fatty acyl groups, a process to extract them from Mycobacterium tuberculosis, and their use in the treatment or the prophylaxis of tuberculosis.